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602their performance should be
independent of patient charac-
teristics, survival measures require
risk standardization to account
for variations in patient case-mix
across sites so as to facilitate a
more unbiased comparison across
hospitals (3). Although risk-adjustment models for survival already exist for other
medical conditions, such as acute myocardial infarction, heart
failure, and community-acquired pneumonia (4,5), a vali-
dated model to risk-standardize survival after in-hospital
cardiac arrest has not been developed. This current deﬁ-
ciency in the methodology for in-hospital cardiac arrest is
a signiﬁcant barrier to identifying high and low performing
hospitals to disseminate best practices and promote quality
improvement.
To address this current gap in knowledge, we derived and
validated a hierarchical regression model to calculate risk-
standardized hospital rates of survival after in-hospital
cardiac arrest. We used data from Get With The Guide-
lines (GWTG)-Resuscitationdthe largest repository of data
on hospitalized patients with cardiac arrest. We also assessed
the stability of the model over time by examining model
performance in multiple years and different time periods.
Creating this outcome model can assist ongoing efforts to
support ongoing quality assessment and improvement efforts.Methods
Study population. GWTG-Resuscitation, formerly known
as the National Registry of Cardiopulmonary Resuscitation,
is a large, prospective, national quality-improvement registry
of in-hospital cardiac arrest and is sponsored by the AHA.
Its design has been described in detail previously (6). In
brief, trained quality-improvement hospital personnel enroll
all patients with a cardiac arrest (deﬁned as the absence of a
palpable central pulse, apnea, and unresponsiveness) treated
with resuscitation efforts and without do-not-resuscitateAGWTG Science Subcommittee; has received
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; revised manuscript received May 22, 2013,(DNR) orders. Cases are identiﬁed by multiple methods,
including centralized collection of cardiac arrest ﬂow sheets,
reviews of hospital paging system logs, and routine checks
of code carts, pharmacy tracer drug records, and hospital
billing charges for resuscitation medications (6). The registry
uses standardized “Utstein-style” deﬁnitions for all patient
variables and outcomes to facilitate uniform reporting across
hospitals (7,8). In addition, data accuracy is ensured by
rigorous certiﬁcation of hospital staff and use of standardized
software with data checks for completeness and accuracy,
and a prior report had determined an error rate in data
abstraction of 2.4% (6).
From 2000 to 2010, a total of 122,746 patients 18 years
of age or older with an index in-hospital cardiac arrest were
enrolled in GWTG-Resuscitation. Since in-hospital survival
rates have improved over time (9), we restricted our study
population to 48,841 patients from 356 hospitals enrolled
between 2007 and 2010 to ensure that our risk models were
based on a contemporary cohort of patients.
Study outcome and variables. The primary outcome of
interest was survival to hospital discharge, which was ob-
tained from the GWTG-Resuscitation registry.
In all, 26 baseline characteristics were screened as candidate
predictors for the study outcome. These included age (cate-
gorized in 10-year intervals of <50, 50 to 59, 60 to 69, 70 to
79, and 80), sex, location of arrest (categorized as intensive
care, monitored unit, nonmonitored unit, emergency room,
procedural/surgical area, and other), and initial cardiac arrest
rhythm (ventricular ﬁbrillation, pulseless ventricular tachy-
cardia, asystole, pulseless electrical activity). In addition, the
following comorbidities or medical conditions present before
cardiac arrest were evaluated for the model: heart failure,
myocardial infarction, or diabetes mellitus; renal, hepatic, or
respiratory insufﬁciency; baseline evidence of motor, cogni-
tive, or functional deﬁcits (CNS depression); acute stroke;
acute non-stroke neurologic disorder; pneumonia; hypoten-
sion; sepsis; major trauma; metabolic or electrolyte abnor-
mality; and metastatic or hematologic malignancy. Finally,
we considered for model inclusion several critical care inter-
ventions (mechanical ventilation, intravenous vasopressor
support, pulmonary artery catheter, intra-aortic balloon pump,
or dialysis) already in place at the time of cardiac arrest. Race
was not considered for model inclusion, as prior studies have
found that racial differences in survival after in-hospital
cardiac arrest are partly mediated by differences in hospital
care quality for blacks and whites (3,10).
Model development and validation. We randomly selected
two-thirds of the study population for the derivation cohort
and one-third for the validation cohort. We conﬁrmed
that a similar proportion of patients from each hospital and
calendar year were represented in the derivation and valida-
tion cohorts. Baseline differences between patients in the
derivation and validation cohorts were evaluated using chi-
square tests for categorical variables and Student t tests for
continuous variables. Because of the large sample size, we
also evaluated for signiﬁcant differences between the 2 cohorts
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Based on prior work, a standardized difference of >10 was
used to deﬁne a signiﬁcant difference (11).
Within the derivation sample, multivariable models were
constructed to identify signiﬁcant predictors of in-hospital
survival. Because our primary objective was to derive risk-
standardized survival rates for each hospital, which would
require us to account for clustering of observations within
hospitals, we used hierarchical logistic regression models for
our analyses (12). By using hierarchical models to estimate
the log-odds of in-hospital survival as a function of demo-
graphic and clinical variables (both ﬁxed effects) and a
random effect for each hospital, this approach allowed us to
assess for hospital variation in risk-standardized survival
rates after accounting for patient case-mix.
We considered for model inclusion the candidate variables
previously described in the Study Outcome and Variables
section. Multicollinearity between covariates was assessed for
each variable before inclusion (13). To ensure parsimony and
inclusion of only those variables that provided incremental
prognostic value, we employed the approximation of full
model methodology for model reduction (14). The contri-
bution of each signiﬁcant model predictor was ranked, and
variables with the smallest contribution to the model were
sequentially eliminated. This was an iterative process until
further variable elimination led to a greater than 5% loss in
model prediction as compared with the initial full model.
Model discrimination was assessed with the C-statistic,
and model validation was performed in the remaining one-
third of the study cohort by examining observed versus pre-
dicted plots. We also evaluated the robustness of our ﬁndings
by reconstructing the models with data from: 1) only 2010;
2) 2009 to 2010; and 3) 2008 to 2010, and comparing the
predictors and estimates of these models with that from the
main study period (from 2007 to 2010). On validation of the
model, we pooled patients from the derivation and validation
cohorts and reconstructed a ﬁnal hierarchical regression
model to derive estimates from the entire study sample for
risk standardization.
Hospital risk-standardized survival rates. Using the
hospital-speciﬁc estimates (i.e., random intercepts) from the
hierarchical models, we then calculated risk-standardized
survival rates for the 272 hospitals with at least 10 cardiac
arrest cases by multiplying the registry’s unadjusted survival
rate by the ratio of a hospital’s predicted to expected survival
rate. We used the ratio of predicted to expected outcomes
(described in the following text) instead of the ratio of
observed to expected outcomes to overcome analytical issues
that have been described for the latter approach (15–17).
Speciﬁcally, our approach ensured that all hospitals,
including those with relatively small case volumes, would
have appropriate risk standardization of their cardiac arrest
survival rates.
For these calculations, the expected hospital number of
cardiac arrest survivors is the number of cardiac arrest
survivors expected at the hospital if the hospital’s patientswere treated at a “reference” hospital (i.e., the average
hospital-level intercept from all hospitals in GWTG-
Resuscitation). This was determined by regressing patients’
risk factors and characteristics on in-hospital survival with all
hospitals in the sample, then applying the subsequent esti-
mated regression coefﬁcients to the patient characteristics
observed at a given hospital, and then summing the expected
number of deaths. In effect, the expected rate is a form of
indirect standardization. In contrast, the predicted hospital
outcome is the number of survivors at a speciﬁc hospital. It
is determined in the same way that the expected number of
deaths is calculated, except that the hospital’s individual
random effect intercept is used. The risk-standardized
survival rate was then calculated by the ratio of predicted to
expected survival rate, multiplied by the unadjusted rate for
the entire study sample.
The effects of risk standardization on unadjusted hospital
rates of survival were then illustrated with descriptive plots
and statistics. In addition, we examined the absolute change
(either positive or negative) in percentile rank for each
hospital after risk standardization. This approach overcomes
the inherent limitation of just examining the proportion of
hospitals that are reclassiﬁed out of the top quintile with
risk standardization, as some hospitals may be reclassiﬁed
with only a 1% decrease in percentile rank (e.g., from 80%
percentile to 79% percentile), whereas other hospitals would
require up to a 20% decrease in percentile rank to be reclas-
siﬁed (e.g., hospitals with an unadjusted 99% percentile rank).
Because rates of do-not-resuscitate (DNR) orders may
vary across hospitals and inﬂuence rates of in-hospital
cardiac arrest survival, we conducted the following sensi-
tivity analysis to examine the robustness of our ﬁndings. For
hospitals in the lower 2 quartiles of risk-standardized sur-
vival, we assumed that the rate of DNR status for all ad-
missions was 5%. We then assigned DNR rates at hospitals
in the top and second highest quartiles to be 100% and 50%,
respectively, greater than that of the lower 2 quartiles. We
assumed that the rate of in-hospital cardiac arrest for DNR
patients to be 5% and calculated the number of cardiac
arrests at each hospital that would have occurred if no
patients were made DNR. For instance, for a hospital in
the highest quartile of survival with 10,000 annual admis-
sions, an additional 50 cardiac arrests (10,000  0.10 [DNR
rate]  0.05 [rate of cardiac arrest]) were added to the
denominator for each year of data submission.
For each of these “imputed” patients, we assigned an age
of 80 years and 1 of the following characteristics: renal
insufﬁciency, cancer, or hypotension. We then recalculated
risk-standardized survival rates for the entire hospital sample
and examined what proportion of hospitals in the original
analysis was no longer classiﬁed in their quartile of risk-
standardized hospital survival rates. If only a minority of
hospitals were recategorized into a different quartile, that
would suggest that our classiﬁcation of hospitals in the top
2 quartiles was robust and persisted despite a higher DNR
rate for their admitted patients.
Chan et al. JACC Vol. 62, No. 7, 2013
Standardizing Survival for Hospital Cardiac Arrest August 13, 2013:601–9
604All study analyses were performed with SAS version 9.2
(SAS Institute, Cary, North Carolina) and R version 2.10.0
(18). The hierarchical models were ﬁtted with the use of the
GLIMMIX macro in SAS.
Dr. Chan had full access to the data and takes responsi-
bility for its integrity. All authors have read and agree to the
manuscript as written. The institutional review board of the
Mid America Heart Institute waived the requirement of
informed consent, and the AHA approved the ﬁnal manu-
script draft.
Results
Of 48,841 patients in the study cohort, 32,560 were ran-
domly selected for the derivation cohort and 16,281 for the
validation cohort. Baseline characteristics of the patients in
the derivation and validation cohorts were similar, based on
comparisons of both p-values and standardized differences
(Table 1). The mean patient age in the overall cohort was
65.6  16.1 years, 58% were male, and 21% were black.
More than 80% of patients had a nonshockable cardiac
arrest rhythm of asystole or pulseless electrical activity, and
nearly half were already in an intensive care unit during
the arrest. Respiratory insufﬁciency and renal insufﬁciency
were the most prevalent comorbidities, whereas one-quarter
of patients were hypotensive and one-third were receiving
mechanical ventilation at the time of cardiac arrest.
Overall, 10,290 (21.1%) patients with an in-hospital
cardiac arrest survived to hospital discharge. The survival
rates were similar in the derivation (n ¼ 6,844; 21.0%) and
validation cohorts (n ¼ 3,446; 21.2%). A comparison of
baseline characteristics between patients who survived and
did not survive to hospital discharge is provided in Online
Table 1. In general, patients who survived were younger,
more frequently white, more likely to have an initial cardiac
arrest rhythm of ventricular ﬁbrillation or pulseless ventric-
ular tachycardia, and to have fewer comorbidities or inter-
ventions in place (e.g., intravenous vasopressors) at the time
of cardiac arrest.
Initially, 18 independent predictors were identiﬁed in the
derivation cohort with the multivariable model, resulting in
a model C-statistic of 0.738 (Table 2; see Online Table 2 for
variable deﬁnitions). After model reduction to generate
a parsimonious model with no more than 5% loss in model
prediction, our ﬁnal model comprised 9 variables, with only
a small change in the C-statistic (0.734). The predictors in
the ﬁnal model included age, initial cardiac arrest rhythm,
hospital location of arrest, hypotension, septicemia, meta-
static or hematologic malignancy, hepatic insufﬁciency, and
requirement for mechanical ventilation or intravenous vaso-
pressor before cardiac arrest. The beta-coefﬁcient estimates
and adjusted odds ratios are summarized in Table 3. Impor-
tantly, there was no evidence of multicollinearity between
any of these variables (all variance inﬂation factors <1.5).
When the model was tested in the independent validation
cohort, model discrimination was similar (C-statistic of0.737). Calibration was conﬁrmed with observed versus
predicted plots in both the derivation and validation cohorts
(R2 of 0.99 for both). When we repeated the analyses using
data from year 2010 only, 2009 to 2010, and 2008 to 2010,
our model predictors were unchanged, and the estimates of
effect for each predictor were similar.
Figure 1 depicts the unadjusted and risk-standardized
distribution of hospital rates of cardiac arrest survival (see
Online Table 3 for calculations of the risk-standardized
rates). The mean unadjusted hospital survival rate was
21  13%, whereas the mean risk-standardized hospital
survival rate of 21  4% showed a much narrower distri-
bution. Similarly, the median unadjusted hospital survival
rate was 20% (interquartile range 14% to 26%; range 0% to
85%), whereas the interquartile range and range for the risk-
standardized hospital survival rates were substantially
smaller: median of 21% (interquartile range: 19% to 23%;
range 11% to 35%). Nine (3.3%) of the 272 hospitals had
risk-standardized survival rates of 30%, or w50% higher
than the average hospital.
To examine the effect of risk standardization at individual
hospitals, the change in percentile rank for each hospital
was examined (Fig. 2). Of 272 hospitals, 143 (52.6%) had
at least a 10% positive or negative absolute change in per-
centile rank after risk standardization (e.g., hospital ranked
at 39% percentile before and at 53% percentile after risk
standardization). Moreover, 50 hospitals (23.2%) had a
substantial 20% absolute change in percentile rank, with
24 having a 20% or greater increase and 26 having a 20% or
greater decrease.
Finally, we found that our study ﬁndings were unlikely to
be inﬂuenced by higher rates of DNR at hospitals with
higher risk-standardized survival. Only 1 of 68 hospitals in
the top quartile of risk-standardized survival was reclassiﬁed
to a different quartile, even after assuming that hospitals in
the top quartile had DNR rates that were twice the DNR
rate of the lower 2 quartiles. Similarly, only 1 of 68 hospitals
in the second highest quartile of risk-standardized survival
was reclassiﬁed, even after assuming that these hospitals had
DNR rates that were 50% higher than those in the lower
2 quartiles (Online Table 4).
Discussion
Within a large national registry, we derived and validated
a risk-adjustment model for survival after in-hospital cardiac
arrest. The model was based on 9 clinical variables that
are easy to identify and collect. Moreover, the model had
good discrimination and excellent calibration. Importantly,
our model adhered to recommended standards to be
employed for public reporting, including the use of hierar-
chical models, timely and high-quality data, and clearly
deﬁned study population and outcomes (3). As a result, we
believe this model provides a mechanism to generate risk-
standardized survival rates to facilitate more accurate
comparisons of resuscitation outcomes across hospitals.
Table 1 Characteristics of the Derivation and Validation Cohorts
Derivation Cohort
(n ¼ 32,560)
Validation Cohort
(n ¼ 16,281) p Value
Standardized
Difference*
Demographics
Age, yrs 65.6  16.1 65.6  16.0 0.91 0.10
Age, yrs, by deciles 0.54
18 to <50 5,269 (16.2%) 2,594 (15.9%)
50 to 59 5,476 (16.8%) 2,832 (17.4%)
60 to 69 7,137 (21.9%) 3,556 (21.8%)
70 to 79 7,562 (23.2%) 3,793 (23.3%)
80 to 89 7,116 (21.9%) 3,506 (21.5%)
90
Male 18,996 (58.3%) 9,500 (58.4%) 0.99 0.02
Race 0.77
White 22,576 (69.3%) 11,337 (69.6%)
Black 6,678 (20.5%) 3,288 (20.2%)
Other 1,268 (3.9%) 618 (3.8%)
Unknown 2,038 (6.3%) 1,038 (6.4%)
Hispanic 2,254 (6.9%) 1,060 (6.5%) 0.09 1.65
Pre-existing conditions
Respiratory insufﬁciency 13,301 (40.9%) 6,640 (40.8%) 0.89 0.14
Renal insufﬁciency 10,850 (33.3%) 5,358 (32.9%) 0.36 0.88
Arrhythmia 9,974 (30.6%) 4,973 (30.5%) 0.84 0.19
Diabetes mellitus 10,001 (30.7%) 4,928 (30.3%) 0.31 0.97
Hypotension 8,413 (25.8%) 4,308 (26.5%) 0.14 1.42
Heart failure this admission 5,370 (16.5%) 2,678 (16.4%) 0.90 0.12
Prior heart failure 6,278 (19.3%) 3,094 (19.0%) 0.46 0.71
Myocardial infarction this admission 5,184 (15.9%) 2,501 (15.4%) 0.11 1.54
Prior myocardial infarction 4,791 (14.7%) 2,319 (14.2%) 0.16 1.34
Metabolic or electrolyte abnormality 4,765 (14.6%) 2,280 (14.0%) 0.06 1.80
Septicemia 5,519 (17.0%) 2,777 (17.1%) 0.77 0.28
Pneumonia 4,342 (13.3%) 2,239 (13.8%) 0.20 1.22
Metastatic or hematologic malignancy 4,046 (12.4%) 1,997 (12.3%) 0.61 0.49
Hepatic insufﬁciency 2,474 (7.6%) 1,175 (7.2%) 0.13 1.46
Baseline depression in CNS function 3,640 (11.2%) 1,853 (11.4%) 0.51 0.64
Acute CNS non-stroke event 2,250 (6.9%) 1,139 (7.0%) 0.73 0.34
Acute stroke 1,234 (3.8%) 605 (3.7%) 0.69 0.39
Major trauma 1,399 (4.3%) 668 (4.1%) 0.32 0.97
Characteristics of arrest
Cardiac arrest rhythm 0.99
Asystole 10,997 (33.8%) 5,491 (33.7%)
Pulseless electrical activity 15,327 (47.1%) 7,653 (47.0%)
Ventricular ﬁbrillation 3,691 (11.3%) 1,862 (11.4%)
Pulseless ventricular tachycardia 2,545 (7.8%) 1,275 (7.8%)
Location 0.92
Intensive care unit 15,780 (48.5%) 7,809 (48.0%)
Monitored unit 5,034 (15.5%) 2,539 (15.6%)
Nonmonitored unit 5,632 (17.3%) 2,824 (17.3%)
Emergency room 3,307 (10.2%) 1,687 (10.4%)
Procedural or surgical area 2,132 (6.5%) 1,073 (6.6%)
Other 675 (2.1%) 349 (2.1%)
Interventions in place
Mechanical ventilation 10,747 (33.0%) 5,422 (33.3%) 0.51 0.63
Intravenous vasopressor 9,549 (29.3%) 4,800 (29.5%) 0.72 0.34
Pulmonary artery catheter 833 (2.6%) 378 (2.3%) 0.11 1.53
Dialysis 1,163 (3.6%) 598 (3.7%) 0.57 0.54
Intra-aortic balloon pump 482 (1.5%) 228 (1.4%) 0.49 0.67
Values are mean  SD or n (%). *For binary variables, because of the large sample size, standardized differences of >10 indicate a signiﬁcant
difference between groups.
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Table 2
Full Model for Predictors of Survival to
Hospital Discharge
Predictor
Beta-Weight
Estimate
Odds
Ratio 95% CI
Age, yrs
<50 0 Reference Reference
50–59 0.0202 0.98 0.88–1.08
60–69 0.0408 0.96 0.87–1.05
70–79 0.2877 0.75 0.68–0.83
80 0.6931 0.50 0.46–0.56
Male 0.0834 0.92 0.87–0.98
Hospital location
Nonmonitored unit 0 Reference Reference
Intensive care unit 0.5653 1.76 1.59–1.93
Monitored unit 0.4700 1.60 1.45–1.78
Emergency room 0.5188 1.68 1.49–1.89
Procedural or surgical area 1.1217 3.07 2.71–3.49
Other 0.6259 1.87 1.54–2.26
Initial cardiac arrest rhythm
Asystole 0 Reference Reference
Pulseless electrical activity 0.0392 1.04 0.97–1.12
Ventricular ﬁbrillation 1.2238 3.40 3.10–3.72
Pulseless ventricular
tachycardia
1.1086 3.03 2.73–3.36
Myocardial infarction this
admission
0.1484 1.16 1.07–1.25
Prior heart failure 0.0619 0.94 0.87–1.01
Renal insufﬁciency 0.2231 0.80 0.75–0.86
Hepatic insufﬁciency 0.6539 0.52 0.45–0.59
Hypotension 0.4463 0.64 0.59–0.69
Septicemia 0.4308 0.65 0.59–0.71
Acute stroke 0.3147 0.73 0.63–0.86
Diabetes mellitus 0.1310 1.14 1.06–1.21
Metabolic/electrolyte
abnormality
0.1625 0.85 0.77–0.94
Metastatic or hematologic
malignancy
0.7550 0.47 0.42–0.53
Major trauma 0.3425 0.71 0.60–0.83
Mechanical ventilation 0.5447 0.58 0.54–0.63
Dialysis 0.3011 0.74 0.61–0.90
Intravenous vasopressor 0.7340 0.48 0.44–0.52
CI ¼ conﬁdence interval.
Table 3
Final Reduced Model for Predictors of Survival
to Discharge
Predictor
Beta-Weight
Estimate
Odds
Ratio 95% CI
Age, yrs
<50 0 Reference Reference
50–59 0.0031 1.00 0.91–1.11
60–69 0.0096 0.99 0.90–1.09
70–79 0.2560 0.77 0.70–0.85
80 0.6562 0.52 0.47–0.57
Initial cardiac arrest rhythm
Asystole 0 Reference Reference
Pulseless electrical activity 0.0478 1.05 0.98–1.13
Ventricular ﬁbrillation 1.2631 3.54 3.24–3.86
Pulseless ventricular
tachycardia
1.1289 3.09 2.79–3.43
Hospital location
Nonmonitored unit 0 Reference Reference
Intensive care unit 0.5643 1.76 1.60–1.93
Monitored unit 0.4816 1.62 1.46–1.79
Emergency room 0.5618 1.75 1.56–1.97
Procedural or surgical area 1.1550 3.17 2.80–3.60
Other 0.6210 1.86 1.54–2.25
Hypotension 0.4749 0.62 0.57–0.67
Sepsis 0.4879 0.61 0.56–0.68
Metastatic or hematologic
malignancy
0.7345 0.48 0.43–0.53
Hepatic insufﬁciency 0.7240 0.48 0.42–0.56
Mechanical ventilation 0.5662 0.57 0.53–0.61
Intravenous vasopressor 0.7329 0.48 0.44–0.52
CI ¼ conﬁdence interval.
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in-hospital cardiac arrest exists (2), there are currently efforts
to measure hospital performance for this condition. The
Joint Commission, for instance, is developing a number of
metrics to assess hospital performance in resuscitation. The
AHA’s GWTG-Resuscitation national registry has also
developed a number of target benchmarks to highlight
hospitals with exceptional performance. Most of these
performance metrics are process-oriented, such as time to
deﬁbrillation and time to initiation of cardiopulmonary
resuscitation, and are therefore independent of confounding
by patient case-mix. However, both organizations also plan
to proﬁle survival outcomes after cardiac arrest.
In contrast to process measures, several key challenges
exist in comparing survival outcomes across hospitals. First,
and most important, hospital variation in survival may besimply due to heterogeneity in patients’ case-mix. Hospitals
with cardiac arrest patients who have higher illness acuity
may have lower survival rates. To date, a risk-adjustment
model that uses appropriate analytical techniques to ac-
count for nesting of data within hospitals (i.e., hierarchical
models) has not been derived and validated. Although
several multivariable models for in-hospital cardiac arrest
exist (19,20), these have not been validated, were based on
less contemporary cohorts of patients, and used analytical
approaches that do not adequately account for clustering of
patients within hospitals. Therefore, these other models may
have under-estimated standard errors, which can lead to type
I errors in inferences regarding statistical signiﬁcance and
inappropriately label certain hospitals as performing better,
or worse, than average (21). Moreover, unlike hierarchical
models used in this study, these other approaches do not
have a mechanism to weight the number of observations
contributed by each hospital to account for differences in the
sample sizes across hospitals.
Second, prior efforts in risk standardization for other
disease conditions have been based on the ratio of observed
to expected outcomes. This approach has signiﬁcant limi-
tations (16,17), especially the inability to risk-standardize
rates for sites with low case volumes. In this study, we
overcame both of these barriers by deriving and validating
a risk-adjustment model using hierarchical random-effects
Figure 1 Distribution of Unadjusted and Risk-Standardized Hospital Survival Rates for In-Hospital Cardiac Arrest
(A) Observed hospital rates: the number of hospitals for each range of survival rates is displayed. A total of 276 hospitals with 10 in-hospital cardiac arrest cases were
evaluated. (B) Risk-standardized hospital rates: the number of hospitals for each range of survival rates is displayed. A total of 276 hospitals with 10 in-hospital cardiac
arrest cases was evaluated.
JACC Vol. 62, No. 7, 2013 Chan et al.
August 13, 2013:601–9 Standardizing Survival for Hospital Cardiac Arrest
607models and basing our risk standardization on the ratio of
predicted to expected outcomes (15), thereby allowing us to
generate risk-standardized rates for hospitals in the study.
Without risk standardization, differences in hospital
survival rates for in-hospital cardiac arrest may be due to
differences 1) patient case-mix; and 2) quality of care between
hospitals. From a quality perspective, only the last difference
is of interest. With our risk-standardization approach, which
controlled for differences in patient case-mix across hospitals,
the range of hospital survival rates narrowed enormously,
with the interquartile range decreasing from 12% to 4%. Evenmore importantly, we found that more than half of hospitals
changed in percentile rank by at least 10%, and nearly
a quarter of hospitals changed in percentile rank by 20% or
greater, suggesting a signiﬁcant impact of risk standardiza-
tion (to account for differences in case-mix) in assessing
a hospital’s survival outcomes for in-hospital cardiac arrest.
Both of these ﬁndings suggest that simple comparisons of
unadjusted hospital survival rates would be problematic and
likely to lead to incorrect inferences.
Importantly, despite the reduction in variability with
our risk-adjustment methodology, there remained notable
Figure 2 Hospital Change in Absolute Rank Percentile After Risk Standardization
The change in a hospital’s percentile rank in survival rates for in-hospital cardiac arrest after accounting for patient case-mix is depicted. Of 272 hospitals, 143 (52.6%)
had at least a 10% positive or negative absolute change in percentile rank after risk standardization, and 50 hospitals (23.2%) had a substantial 20% absolute change
in percentile rank.
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608differences in risk-standardized rates of survival. That sug-
gests that some hospitals were able to achieve higher survival
rates than others. For instance, some (9 of 272 [3.3%])
hospitals had risk-standardized survival rates of 30%,
or w50% higher than the average hospital. Which hospital
factors or quality improvement initiatives are associated with
the higher survival outcomes in these hospitals remain
unknown. Therefore, identifying best practices at these
top-performing hospitals should be a priority (22), as
their dissemination to all hospitals has the potential to
signiﬁcantly improve survival for all patients with in-hospital
cardiac arrest.
Study limitations. Our study should be interpreted in the
context of the following limitations. First, although our risk
model was able to account for a number of clinical variables,
unmeasured confounding may exist. Speciﬁcally, our model
did not have information on some prognostic factors, such as
creatinine or the severity level for each comorbid condition.
In addition, thorough documentation of patients’ case-mix
(e.g., comorbidities) and access to telemetry and intensive
care unit monitoring may differ across sites, which could
account for some of the hospital variation in risk-
standardized survival rates. Second, our model did not
adjust for intra-arrest variables (such as quality of cardio-
pulmonary resuscitation and time to deﬁbrillation) which are
known to inﬂuence survival outcomes. However, because
these latter variables are attributes speciﬁc to a hospital’s
performance, their inclusion in a model developed to proﬁle
hospitals for resuscitation performance would be improper
(3). Third, we did not have information on DNR status forall admitted patients or the proportion of deaths with
attempted resuscitation at each hospital, and this rate is likely
to vary across hospitals. Such variation is likely to affect
a hospital’s crude rank performance for cardiac arrest survival.
However, in our sensitivity analyses, we found that a hospital’s
risk-standardized rank performance was relatively unaffected
by variation in DNR rates across sites, thus underscoring the
importance of risk standardization for meaningful compari-
sons of in-hospital cardiac arrest survival across hospitals.
Fourth, our study population was limited to hospitals
participating within the AHA’s GWTG-Resuscitation
program. Therefore, our ﬁndings may not apply to non-
participating hospitals. Fifth, our model was developed in
patients with in-hospital cardiac arrest. Because the reasons
for cardiac arrest and comorbidity burden differ for patients
with out-of-hospital cardiac arrest, our ﬁndings do not apply
to cardiac arrests occurring outside hospitals. Finally, we
have not developed a model for survival with good neuro-
logical outcome. Although this is an important consider-
ation for patients with in-hospital cardiac arrest and should
be the focus of a future study, our goal was to develop a risk-
standardization model for in-hospital survival, as this is the
outcome proposed by national organizations for a perfor-
mance measure.
Conclusions
Given poor survival outcomes for in-hospital cardiac arrest,
there is growing national interest in developing performance
metrics to benchmark hospital survival for this condition.
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609In this study, we have developed and validated a model to
risk-standardize hospital rates of survival for in-hospital
cardiac arrest. We believe that use of this model to adjust
for patient case-mix represents an advance in ongoing efforts
to proﬁle hospitals in resuscitation outcomes, with the hope
that clinicians and administrators will be stimulated to
develop novel and effective quality improvement strategies to
improve their hospital’s performance.
Reprint requests and correspondence: Dr. Paul S. Chan, Mid
America Heart Institute, 5th Floor, 4401 Wornall Road, Kansas
City, Missouri 64111. E-mail: pchan@cc-pc.com.
REFERENCES
1. Merchant RM, Yang L, Becker LB, et al. Incidence of treated cardiac
arrest in hospitalized patients in the United States. Crit Care Med
2011;39:2401–6.
2. Chan PS, Nichol G, Krumholz HM, Spertus JA, Nallamothu BK.
Hospital variation in time to deﬁbrillation after in-hospital cardiac
arrest. Arch Intern Med 2009;169:1265–73.
3. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical
models used for public reporting of health outcomes: an American
Heart Association Scientiﬁc Statement from the Quality of Care and
Outcomes Research Interdisciplinary Writing Group. Circulation
2006;113:456–62.
4. Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims
model suitable for proﬁling hospital performance based on 30-day
mortality rates among patients with an acute myocardial infarction.
Circulation 2006;113:1683–92.
5. Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims
model suitable for proﬁling hospital performance based on 30-day
mortality rates among patients with heart failure. Circulation 2006;113:
1693–701.
6. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation
of adults in the hospital: a report of 14720 cardiac arrests from the
National Registry of Cardiopulmonary Resuscitation. Resuscitation
2003;58:297–308.
7. Cummins RO, Chamberlain D, Hazinski MF, et al. Recommended
guidelines for reviewing, reporting, and conducting research on
in-hospital resuscitation: the in-hospital “Utstein style.” American
Heart Association. Circulation 1997;95:2213–39.
8. Jacobs I, Nadkarni V, Bahr J, et al. Cardiac arrest and cardiopulmonary
resuscitation outcome reports: update and simpliﬁcation of the
Utstein templates for resuscitation registries. A statement for healthcare
professionals from a task force of the International Liaison Committee
on Resuscitation (American Heart Association, European Resuscita-
tion Council, Australian Resuscitation Council, New ZealandResuscitation Council, Heart and Stroke Foundation of Canada,
InterAmerican Heart Foundation, Resuscitation Councils of Southern
Africa). Circulation 2004;110:3385–97.
9. Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM,
Chan PS. Trends in survival after in-hospital cardiac arrest. N Engl J
Med 2012;367:1912–20.
10. Chan PS, Nichol G, Krumholz HM, et al. Racial differences in survival
after in-hospital cardiac arrest. JAMA 2009;302:1195–201.
11. Austin PC. Using the standardized difference to compare the preva-
lence of a binary variable between two groups in observational research.
Comm Stat Sim Comput 2009;38:1228–34.
12. Goldstein H. Multilevel Statistical Models. London: Edward Arnold;
1995.
13. Belsley DA, Kuh E, Welsch RE. Regression Diagnostics: Identifying
Inﬂuential Data and Sources of Collinearity. New York, NY: John
Wiley & Sons; 1980.
14. Harrell FE. Logistic Regression and Survival Analysis, Regression
Modeling Strategies With Applications to Linear Models. New York,
NY: Springer-Verlag; 2001.
15. Shahian DM, Torchiana DF, Shemin RJ, Rawn JD, Normand SL.
Massachusetts cardiac surgery report card: implications of statistical
methodology. Ann Thorac Surg 2005;80:2106–13.
16. Christiansen CL, Morris CN. Improving the statistical approach to
health care provider proﬁling. Ann Intern Med 1997;127:764–8.
17. Normand SL, Glickman ME, Gatsonis CA. Statistical methods for
proﬁling providers of medical care: issues and applications. J Am Stat
Assoc 1997;92:803–14.
18. R Development Core Team (2008). R: a language and environment for
statistical computing. Vienna, Austria: R Foundation for Statistical
Computing. Available at: http://www.R-project.org.
19. Larkin GL, Copes WS, Nathanson BH, Kaye W. Pre-resuscitation
factors associated with mortality in 49,130 cases of in-hospital cardiac
arrest: a report from the National Registry for Cardiopulmonary
Resuscitation. Resuscitation 2010;81:302–11.
20. Chan PS, Krumholz HM, Nichol G, Nallamothu BK. Delayed time to
deﬁbrillation after in-hospital cardiac arrest. N Engl J Med 2008;358:
9–17.
21. Austin PC, Tu JV, Alter DA. Comparing hierarchical modeling with
traditional logistic regression analysis among patients hospitalized with
acute myocardial infarction: should we be analyzing cardiovascular
outcomes data differently? Am Heart J 2003;145:27–35.
22. Chan PS, Nallamothu BK. Improving outcomes following in-hospital
cardiac arrest: life after death. JAMA 2012;307:1917–8.Key Words: cardiac arrest - risk adjustment - variation in care.
APPENDIX
For a list of the AHA GWTG-Resuscitation (formerly, the National Registry of
Cardiopulmonary Resuscitation) investigators and supplementary tables,
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